Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The treatment is safe and shows promise for metastatic breast cancer.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

The treatment was not recommended due to limited effectiveness and significant side effects.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Enhancing immune response can improve cancer treatment effectiveness.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Blocking certain proteins on immune cells may help treat alopecia areata.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.